NO20071921L - Fremgangsmater for behandling av epileptogenese og epilepsi - Google Patents

Fremgangsmater for behandling av epileptogenese og epilepsi

Info

Publication number: NO20071921L
Authority: NO; Norway
Prior art keywords: group; phenyl; alkyl; epilepsy; methods
Prior art date: 2004-09-16

Application number

NO20071921A

Other languages

English (en)

Norwegian (no)

Inventor

Boyu Zhao

Roy E Twyman

Robert Gordon

Yong Moon Choi

Gerald P Novak

Carlos R Plata-Ssalaman

H Steve White

Original Assignee

Janssen Pharmaceutica Nv

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-09-16

Filing date

2007-04-16

Publication date

2007-06-12

2007-04-16 Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv

2007-06-12 Publication of NO20071921L publication Critical patent/NO20071921L/no

Links

206010015037 epilepsy Diseases 0.000 title abstract 2
230000008579 epileptogenesis Effects 0.000 title abstract 2
125000004178 (C1-C4) alkyl group Chemical group 0.000 abstract 3
125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 3
125000000229 (C1-C4)alkoxy group Chemical group 0.000 abstract 1
ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 abstract 1
WKBOTKDWSSQWDR-UHFFFAOYSA-N Bromine atom Chemical compound [Br] WKBOTKDWSSQWDR-UHFFFAOYSA-N 0.000 abstract 1
ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 1
PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 1
UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
GDTBXPJZTBHREO-UHFFFAOYSA-N bromine Substances BrBr GDTBXPJZTBHREO-UHFFFAOYSA-N 0.000 abstract 1
229910052794 bromium Inorganic materials 0.000 abstract 1
229910052801 chlorine Inorganic materials 0.000 abstract 1
239000000460 chlorine Substances 0.000 abstract 1
150000001875 compounds Chemical class 0.000 abstract 1
125000004093 cyano group Chemical group *C#N 0.000 abstract 1
150000002148 esters Chemical class 0.000 abstract 1
229910052731 fluorine Inorganic materials 0.000 abstract 1
239000011737 fluorine Substances 0.000 abstract 1
229910052736 halogen Inorganic materials 0.000 abstract 1
125000005843 halogen group Chemical group 0.000 abstract 1
150000002367 halogens Chemical group 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
230000002401 inhibitory effect Effects 0.000 abstract 1
229910052740 iodine Inorganic materials 0.000 abstract 1
239000011630 iodine Substances 0.000 abstract 1
125000000449 nitro group Chemical group [O-][N+](*)=O 0.000 abstract 1
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1
125000001424 substituent group Chemical group 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/27—Esters, e.g. nitroglycerine, selenocyanates of carbamic or thiocarbamic acids, meprobamate, carbachol, neostigmine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/325—Carbamic acids; Thiocarbamic acids; Anhydrides or salts thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Epidemiology (AREA)
Emergency Medicine (AREA)
Biomedical Technology (AREA)
Organic Chemistry (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Pain & Pain Management (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

NO20071921A 2004-09-16 2007-04-16 Fremgangsmater for behandling av epileptogenese og epilepsi NO20071921L (no)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US61027604P	2004-09-16	2004-09-16
US69862505P	2005-07-12	2005-07-12
US70724205P	2005-08-11	2005-08-11
PCT/US2005/032861 WO2006033947A2 (en)	2004-09-16	2005-09-15	Use of 2-phenyl-1, 2-ethanediol- (di) carbamates for treating epileptogenesis and epilepsy

Publications (1)

Publication Number	Publication Date
NO20071921L true NO20071921L (no)	2007-06-12

Family

ID=36087909

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO20071921A NO20071921L (no)	2004-09-16	2007-04-16	Fremgangsmater for behandling av epileptogenese og epilepsi

Country Status (22)

Country	Link
US (2)	US20060194873A1 (es)
JP (1)	JP2008513466A (es)
KR (1)	KR20070057939A (es)
CN (1)	CN101056629B (es)
AT (1)	ATE464044T1 (es)
AU (1)	AU2005287174B2 (es)
BR (1)	BRPI0515374A (es)
CA (1)	CA2580640A1 (es)
CO (1)	CO6382111A2 (es)
CR (1)	CR9053A (es)
DE (1)	DE602005020667D1 (es)
DK (1)	DK1809273T3 (es)
EA (1)	EA200700642A1 (es)
ES (1)	ES2342185T3 (es)
HR (1)	HRP20100304T1 (es)
IL (1)	IL181910A0 (es)
MX (1)	MX2007003278A (es)
NO (1)	NO20071921L (es)
NZ (1)	NZ553813A (es)
PT (1)	PT1809273E (es)
RS (1)	RS51269B (es)
WO (1)	WO2006033947A2 (es)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1202720A4 (en) *	1999-08-10	2004-02-25	Uab Research Foundation	USE OF GABA AGONISTS FOR THE TREATMENT OF SPASTIC DISEASES, CONVULSIONS AND EPILEPSY
BRPI0516112A (pt) *	2004-10-15	2008-08-26	Janssen Pharmaceutica Nv	métodos para neuroproteção
PE20070325A1 (es) *	2005-06-29	2007-05-12	Alza Corp	Formas de dosificacion oral que comprenden compuestos derivados de carbamato
US20070021500A1 (en) *	2005-07-12	2007-01-25	Twyman Roy E	Methods for neuroprotection
US20070043120A1 (en) *	2005-08-18	2007-02-22	Bettina Beyreuther	Therapeutic combination for painful medical conditions
EA019757B1 (ru)	2006-06-15	2014-06-30	ЮСиБи ФАРМА ГМБХ	Фармацевтическая композиция с синергетическим противосудорожным эффектом
US7632963B2 (en) *	2006-10-06	2009-12-15	Janssen Pharmaceutica Nv	Crystal of (S)-(+)-2-(2-chlorophenyl)-2-hydroxy-ethyl carbamate
JP2010508354A (ja) *	2006-10-31	2010-03-18	ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ	広汎性発達障害の処置
US9018253B2 (en)	2010-07-02	2015-04-28	Bio-Pharm Solutions Co., Ltd.	Phenylcarbamate compound and muscle relaxant containing the same
US8609849B1 (en)	2010-11-30	2013-12-17	Fox Chase Chemical Diversity Center, Inc.	Hydroxylated sulfamides exhibiting neuroprotective action and their method of use
RU2632659C2 (ru)	2011-12-27	2017-10-09	Байо-Фарм Солюшнс Ко., Лтд.	Фенилкарбаматные соединения для применения в предупреждении или лечении эпилепсии
JP6062077B2 (ja) *	2013-03-12	2017-01-18	バイオ−ファームソリューションズカンパニーリミテッド	小児てんかん及びてんかん関連症侯群の予防又は治療用フェニルカルバメート化合物｛ｐｈｅｎｙｌｃａｒｂａｍａｔｅｃｏｍｐｏｕｎｄｓｆｏｒｕｓｅｉｎｐｒｅｖｅｎｔｉｎｇｏｒｔｒｅａｔｉｎｇｐｅｄｉａｔｒｉｃｅｐｉｌｅｓｙａｎｄｅｐｉｌｅｓｙ−ｒｅｌａｔｅｄｓｙｎｄｒｏｍｅｓ｝
WO2014142547A1 (en) *	2013-03-12	2014-09-18	Bio-Pharm Solutions Co., Ltd.	Phenyl carbamate compound and a composition for neuroprotection comprising the same
CN109071424B (zh) *	2016-02-29	2022-01-14	生物药品解决方案有限公司	氨基磺酸酯衍生物化合物、其制备方法及用途
CN106053510A (zh) *	2016-05-16	2016-10-26	山东省分析测试中心	一种基于氢核磁共振快速测定普瑞巴林原料药纯度的方法
KR102421006B1 (ko) *	2016-05-19	2022-07-14	에스케이바이오팜 주식회사	두통의 예방학적 치료를 위한 카바메이트 화합물의 용도
JP2023536341A (ja) *	2020-08-06	2023-08-24	エスケーバイオファーマスティカルズカンパニーリミテッド	カルバメート化合物を含む経口用固形製剤及びその製造方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3313692A (en) *	1958-04-21	1967-04-11	Armour Pharma	Method of inducing calming and muscle relaxation with carbamates
US3265728A (en) *	1962-07-18	1966-08-09	Armour Pharma	Substituted phenethyl carbamates
US20010034365A1 (en) *	1996-01-16	2001-10-25	Choi Yong Moon	Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
US5698588A (en) *	1996-01-16	1997-12-16	Yukong Limited	Halogen substituted carbamate compounds from 2-phenyl-1,2-ethanediol
AU3304997A (en) *	1996-05-31	1998-01-05	Southern Illinois University	Methods of modulating aspects of brain neural plasticity by vagus nerve stimulation
JP2002536409A (ja) *	1999-02-09	2002-10-29	ユニバーシティオブバージニアパテントファウンデーション	フェルバメートから誘導される化合物
CA2379365C (en) *	1999-07-26	2009-11-17	Sk Corporation	Transnasal anticonvulsive compositions and modulated process
DE60223506T2 (de) *	2001-02-27	2008-09-18	Ortho-Mcneil Pharmaceutical, Inc.	Carbamatverbindungen zur vorbeugung oder behandlung bipolarer erkrankungen
DE60220043T2 (de) *	2001-02-27	2008-01-10	Ortho-Mcneil Pharmaceutical, Inc.	Carbamatverbindungen zur vorbeugung oder behandlung von neurodegenerativen störungen
HUP0303243A3 (en) *	2001-02-27	2012-07-30	Ortho Mcneil Pharm Inc	Carbamate compounds for use in preventing and treating bipolar disorder

2005
- 2005-09-15 PT PT05810288T patent/PT1809273E/pt unknown
- 2005-09-15 NZ NZ553813A patent/NZ553813A/en not_active IP Right Cessation
- 2005-09-15 CN CN2005800387418A patent/CN101056629B/zh not_active Expired - Fee Related
- 2005-09-15 CA CA002580640A patent/CA2580640A1/en not_active Abandoned
- 2005-09-15 AT AT05810288T patent/ATE464044T1/de active
- 2005-09-15 ES ES05810288T patent/ES2342185T3/es not_active Expired - Lifetime
- 2005-09-15 HR HR20100304T patent/HRP20100304T1/hr unknown
- 2005-09-15 US US11/227,247 patent/US20060194873A1/en not_active Abandoned
- 2005-09-15 JP JP2007532446A patent/JP2008513466A/ja active Pending
- 2005-09-15 RS RSP-2010/0264A patent/RS51269B/sr unknown
- 2005-09-15 DK DK05810288.0T patent/DK1809273T3/da active
- 2005-09-15 AU AU2005287174A patent/AU2005287174B2/en not_active Expired - Fee Related
- 2005-09-15 WO PCT/US2005/032861 patent/WO2006033947A2/en not_active Ceased
- 2005-09-15 DE DE602005020667T patent/DE602005020667D1/de not_active Expired - Lifetime
- 2005-09-15 KR KR1020077008402A patent/KR20070057939A/ko not_active Ceased
- 2005-09-15 EA EA200700642A patent/EA200700642A1/ru unknown
- 2005-09-15 BR BRPI0515374-3A patent/BRPI0515374A/pt not_active IP Right Cessation
- 2005-09-15 MX MX2007003278A patent/MX2007003278A/es active IP Right Grant
2007
- 2007-03-13 IL IL181910A patent/IL181910A0/en unknown
- 2007-03-29 CO CO07031825A patent/CO6382111A2/es not_active Application Discontinuation
- 2007-04-13 CR CR9053A patent/CR9053A/es not_active Application Discontinuation
- 2007-04-16 NO NO20071921A patent/NO20071921L/no not_active Application Discontinuation
- 2007-11-15 US US11/940,710 patent/US20110152362A1/en not_active Abandoned

Also Published As

Publication number	Publication date
ATE464044T1 (de)	2010-04-15
EA200700642A1 (ru)	2007-10-26
CO6382111A2 (es)	2012-02-15
AU2005287174B2 (en)	2012-01-12
DK1809273T3 (da)	2010-08-02
US20110152362A1 (en)	2011-06-23
MX2007003278A (es)	2007-10-08
WO2006033947A2 (en)	2006-03-30
CA2580640A1 (en)	2006-03-30
PT1809273E (pt)	2010-05-10
HK1105583A1 (en)	2008-02-22
BRPI0515374A (pt)	2008-07-22
JP2008513466A (ja)	2008-05-01
DE602005020667D1 (de)	2010-05-27
KR20070057939A (ko)	2007-06-07
NZ553813A (en)	2010-09-30
ES2342185T3 (es)	2010-07-02
US20060194873A1 (en)	2006-08-31
CR9053A (es)	2009-10-30
CN101056629B (zh)	2012-01-11
RS51269B (sr)	2010-12-31
IL181910A0 (en)	2007-07-04
HRP20100304T1 (hr)	2010-09-30
CN101056629A (zh)	2007-10-17
WO2006033947A3 (en)	2006-06-29
AU2005287174A1 (en)	2006-03-30

Legal Events

Date	Code	Title	Description
2012-04-30	FC2A	Withdrawal, rejection or dismissal of laid open patent application

Publication	Publication Date	Title
IL181910A0 (en)	2007-07-04	Use of 2-phenyl-1,2-ethanediol-(di) carbamates for treating epileptogenesis and epilepsy
ECSP088179A (es)	2008-03-26	Compuestos de carbamato para usarse en el tratamiento de desordenes neurodegenerativos
NO20080877L (no)	2008-02-19	Fremgangsmater for behandling av substansrelaterte forstyrrelser
YU67703A (sh)	2006-08-17	Karbamatna jedinjenja za upotrebu u sprečavanju ili lečenju poremećaja kretanja
MY138156A (en)	2009-04-30	Carbamate compounds for use in preventing or treating neurodegenerative disorders
IL157590A0 (en)	2004-03-28	Carbamate compounds for use in preventing or treating bipolar disorder
TW200744575A (en)	2007-12-16	Methods of treating epileptogenesis
IL157594A0 (en)	2004-03-28	Carbamate compounds for use in preventing or treating anxiety disorders
MX2009004553A (es)	2009-11-10	Metodos para el tratamiento de trastornos cocleares y vestibulares.
EA200700871A1 (ru)	2007-10-26	Способы нейропротекции
TW200701978A (en)	2007-01-16	Methods of treating epileptogenesis and epilepsy
IL159847A0 (en)	2004-06-20	Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain
MY136733A (en)	2008-11-28	Carbamate compounds for use in preventing or treating psychotic disorders
CY1110672T1 (el)	2015-06-10	Χρηση των 2- φαινυλ-1,2-αιθανοδιολης- (δι) καρβαμικων για θεραπεια επιληπτογενεσης
MY149385A (en)	2013-08-30	Methods for treating substance-related disorders